Gilead Sciences (GILD): NASDAQ:GILD We're aiming to diversify our portfolio beyond just tech stocks and the tech sector. We're now focusing on companies in the pharmaceutical industry, such as Gilead Sciences. Analyzing the weekly chart, we observed the largest surge since 2010 for Wave (3). We believe we've also completed Wave (4) at $56.56. The peak was at...
Accumulation followed by Huge Volume . Cup & Handle pattern visible in Weekly TF. Good for Short Term. Target 160 ,200. Disclaimer : This is not a Buy or Sell recommendation. I am not SEBI Registered. Please consult your financial advisor before making any investments . This is for Educational purpose only.
momentum stock stabilising . lets see if it can fly
ALKEM is Near all time high Alkem is in a Rising channel and Resistance is working from last 8 years Stock is facing resistance around 5500 for the further upside Stock need to cross 5500 If stock tanks then we might see level of 3100-3200 3100-3200 is strongest support and one should not miss opportunity to BUY around these levels. Thank You...
Introduction Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) is at the forefront of developing innovative cancer treatments, with a keen focus on leveraging their proprietary switch-control kinase inhibitor platform. The company has made significant strides, particularly with its flagship product, QINLOCK, and the promising pipeline candidate vimseltinib, aiming...
ATH Breakout. Rounding Bottom Structure. Good for Short term and Long term. Disclaimer : This is not a Buy or Sell recommendation. I am not SEBI Registered. Please consult your financial advisor before making any investments . This is for Educational purpose only.
Axsome Therapeutics - NASDAQ:AXSM ▫️ Entered a position in Oct 2022 on the bounce off the 200 week SMA (averaging $50.77c per share) ▫️ That position is presently in 73% profit ▫️ I have no intention of selling at present as we have a strong underside support from the 200 week MA, the 200 day MA and high volume trading zone from $70-78. ▫️ This a longer term...
Eli Lilly - NYSE:LLY Earnings Rep: $2.49 ✅ Exp: $2.29 - 8.45% HIGHER Revenue Rep: $9.35b ✅ Exp: $8.94b - 4.55% HIGHER Company Summary Eli Lilly is the worlds 9th largest company by market cap at $670b and they have reported positive earnings and revenue both coming in higher than expected for Q4 2023. The pharmaceutical giant booked fourth-quarter...
Entry - at 398 or 417 SL - 3% at both entries TGT - 520+
Entry Possible above 950 level SL - 720 Short term Target - 1190 Long term Target - 1500 Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you...
A short two minute overview of Biocon and levels to watch. Before taking any trade please do your own research. This is only an insight from us thank you
as you can see this could be a huge Symmetrical triangle, like in the case of Bitcoin and S&P this means a change of trend, and a potential 120%
Technically Pharma index is on the verge of giving a cup and handle like breakout in addition to news of new COVID variant making waves. The Pharma index also looking very buoyant. If this particular index can give a closing above 16515 there can be an upsurge 16734 or even 17177 levels taking the index constituents higher along with it. Major companies in...
Stock seems to be in a very good buying and could potentially witness an upside rally. Reasons are stated below : 750-780 is a very strong support zone. Doji candle formed on daily timeframe. 200EMA support on daily timeframe. 50EMA support on daily timeframe. Stock is in an uptrend. Higher-high formation. TARGET : 848 // 911 // 975 // 1130 // 1342 SL...
should be the next crispr or illumina ... it supplies stuff to MODERNA it could be the secret sauce in pre diagnotics or preventing diseases before they become serious currently winding down and allocation of shares to serious players and strong hands with conviction in the Ai Tech Cum Biologics
GRANULES INDIA SHARE BUY NOW ON 288 SELL AFTER ATLEAST PROFIT OF 28 % ITS A INVESTMENT RECOS FOR INTRA RECOS wsip me 8459 22 0202 Granules India Limited is a pharmaceutical company that offers a wide range of products and services. The company has a robust business model, with a strong focus on research and development, which allows it to stay ahead of the...
Bacil Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of bulk pharmaceutical drugs. Additionally, the company produces herbal extracts, drug intermediates, and other pharmaceutical products, including branded formulations, generic products, and OTC medications. Bacil Pharma's domestic operations are spread throughout India, and...